Study of the effect of linezolid on haematologic outcomes in newly diagnosed acute myeloid leukaemia patients.

Trial Profile

Study of the effect of linezolid on haematologic outcomes in newly diagnosed acute myeloid leukaemia patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Nov 2016

At a glance

  • Drugs Linezolid (Primary)
  • Indications Gram-positive infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top